MiR-8080 Recruited by Luteolin Enhances the Chemotherapeutic Effect of Enzalutamide in 22Rv1 CRPC (IMAGE)
Caption
MiR-8080 recruited by luteolin enhances the chemotherapeutic effect of enzalutamide in 22Rv1 CRPC tumor (A) MiR-8080 can bind the 3'-untranslated region of AR-V7. (B-D) Effect of luteolin (Lut) on the chemotherapeutic efficacy of enzalutamide (Enz) in 22Rv1 xenografts in castrated nude mice. (B) Tumor volumes of 22Rv1 xenografts. (C) Quantitative miR-8080 expression by qRT-PCR in 22Rv1 xenografts. (D) Western blotting analysis for AR-V7 in 22Rv1 xenografts.
Credit
© Aya Naiki-Ito
Usage Restrictions
None
License
Licensed content